Four antigenically different strains of infectious bursal disease viru
s (IBDV), characterized by their reactivities with a panel of neutrali
zing monoclonal antibodies (MAbs), were selected to determine the mole
cular basis of antigenic variation. The large genome segment A, encodi
ng the structural proteins of the U.S. variants GLS, DS326, E/Del and
the vaccine strain D78, was cloned and sequenced. Comparison of the de
duced amino acid sequences of the U.S. variants with other IBDV strain
s showed that most of the amino acid substitutions occur in the centra
l region between residues 212 to 332, especially in the two hydrophili
c regions between residues 212 to 223 and residues 314 to 324 of VP2 p
rotein. By comparing the amino acid sequences of these variant viruses
and their reactivities with IBDV specific MAbs, the putative amino ac
ids involved in the formation of virus-neutralizing epitopes were iden
tified. Comparison of the D78 versus PBG98 sequence showed that Gln at
position 249 (Gln249) appears to be critical in binding with MAb B69.
Similarly, comparison of the U.S. variant sequences with other seroty
pe 1 sequences showed unique substitution(s) at residue Glu321 in GLS,
residues Ile286, Asp318, Glu323 in E/Del, and residues Glu311 and Gln
320 in DS326, which could be potential residue(s) involved in the reco
gnition of MAb57, MAb67, and MAb179 epitopes, respectively. Comparison
of the serotype 1 and serotype 2 sequences revealed that serotype 2 O
H strain lacks the conserved amino acid sequence motif, S-W-S-A-S-G-S,
found in all virulent strains, as well as the second hydrophilic peak
region, indicating a possible role of these residues in the serotype
specificty or the pathogenicity of the virus. Phylogenetic analysis of
the IBDV proteins indicated that the U.S. variants are antigenically
different from geographically distant European viruses.